Literature DB >> 19153025

Pulmonary metastasectomy in colorectal cancer: time for a trial.

T Treasure1, L Fallowfield, V Farewell, D Ferry, B Lees, P Leonard, F Macbeth, M Utley.   

Abstract

Pulmonary metastasectomy is undertaken for a range of cancers. The questions we raise here are specifically related to colorectal cancer, the commonest tumour for which pulmonary metastasectomy is undertaken. The primary objective of metastasectomy is to increase survival. There are no randomised trials in support of this practice nor are there any other forms of controlled studies. We present a critical look at the assumption of efficacy for this surgery and propose that a trial is needed and suggest a trial design.

Entities:  

Mesh:

Year:  2009        PMID: 19153025     DOI: 10.1016/j.ejso.2008.12.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

Review 1.  History and present status of pulmonary metastasectomy in colorectal cancer.

Authors:  Tom Treasure; Mišel Milošević; Francesca Fiorentino; Joachim Pfannschmidt
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

2.  Randomized controlled trial of pulmonary metastasectomy in colorectal cancer: PulMiCC International is open in Italy.

Authors:  Marcello Migliore; Belinda Lees; Tom Treasure; Lesley J Fallowfield
Journal:  Oncologist       Date:  2013-04-26

3.  Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer.

Authors:  Stéphane Renaud; Marco Alifano; Pierre-Emmanuel Falcoz; Pierre Magdeleinat; Nicola Santelmo; Olivier Pagès; Gilbert Massard; Jean-François Régnard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-01-16

Review 4.  Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis.

Authors:  Francesca Fiorentino; Ian Hunt; Kristine Teoh; Tom Treasure; Martin Utley
Journal:  J R Soc Med       Date:  2010-02       Impact factor: 5.344

5.  Role of surgical resection in colorectal lung metastases: analysis of 137 patients.

Authors:  Piero Borasio; Mara Gisabella; Andrea Billé; Luisella Righi; Marina Longo; Marco Tampellini; Francesco Ardissone
Journal:  Int J Colorectal Dis       Date:  2010-10-20       Impact factor: 2.571

6.  Factors affecting the outcome of a pulmonary resection for metastatic colorectal cancer: efficacy and pitfalls.

Authors:  Ik Yong Kim
Journal:  J Korean Soc Coloproctol       Date:  2010-10-31

7.  Increased lymphangiogenesis in lung metastases from colorectal cancer is associated with early lymph node recurrence and decreased overall survival.

Authors:  Thomas Schweiger; Christoph Nikolowsky; Thomas Graeter; Gernot Seebacher; Jürgen Laufer; Olaf Glueck; Christoph Glogner; Peter Birner; György Lang; Walter Klepetko; Hendrik Jan Ankersmit; Konrad Hoetzenecker
Journal:  Clin Exp Metastasis       Date:  2015-10-23       Impact factor: 5.150

8.  Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.

Authors:  David A Palma; Cornelis J A Haasbeek; George B Rodrigues; Max Dahele; Michael Lock; Brian Yaremko; Robert Olson; Mitchell Liu; Jason Panarotto; Gwendolyn H M J Griffioen; Stewart Gaede; Ben Slotman; Suresh Senan
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430

9.  Clinical reports of pulmonary metastasectomy for colorectal cancer: a citation network analysis.

Authors:  F Fiorentino; C Vasilakis; T Treasure
Journal:  Br J Cancer       Date:  2011-03-08       Impact factor: 7.640

10.  Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3.

Authors:  Saeed Samarghandian; Jalil Tavakkol Afshari; Saeideh Davoodi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.